Curis Lifesciences Schedules Board Meeting to Approve Half-Yearly Results
Curis Lifesciences Ltd 路 Intimation 路 11 Nov 2026, 5:30 am
Curis Lifesciences Schedules Board Meeting to Approve Half-Yearly Results Curis Lifesciences Limited has scheduled a meeting of its Board of Directors on 11th Nov'26. The board will inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
More announcements from Curis Lifesciences Ltd
- Curis Lifesciences Limited has informed the Exchange regarding 'Standalone andconsolidated financials results for the half year ended on 30th September, 2026'. 路 16 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 11 Nov 2026
- Curis Lifesciences Limited has submitted to the Exchange, the standalone and consolidated financial results for the half year ended September 30, 2026. 路 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about the Board meeting to be held on 11th November, 2026 to consider and approve the unaudited Standalone and Consolidated financial results for the half year ended on September 30, 2026 路 11 Nov 2026
- Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on September 30, 2026 路 19 Oct 2026
- Curis Lifesciences Limited has submitted the Exchange a copy Srutinizers report of 10th Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
- CURIS: Curis Lifesciences Limited has informed the Exchange regarding Proceedings of 10thAnnual General Meeting held on September 29, 2026. 路 30 Sept 2026
- Curis Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 路 08 Sept 2026
